Esperion Therapeutics Inc (ESPR)
Deferred Revenue
$43.53M
Quarterly · Period ending: · USD
ESPR Deferred Revenue
Latest reported$43.53Mperiod ending
Latest reported$43.53Mperiod ending
ESPR Quarterly Deferred Revenue ($0.00 → $43.53M)
Quarterly deferred revenue
High-resolution chart · PNG
ESPR deferred revenue history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Deferred Revenue (USD) |
|---|---|
| 43,531,000 | |
| 34,477,000 | |
| 30,679,000 | |
| 22,313,000 | |
| 4,542,000 | |
| 8,518,000 | |
| 15,078,000 | |
| 20,672,000 | |
| 29,350,000 | |
| 25,402,000 | |
| 19,723,000 | |
| 15,634,000 | |
| 12,157,000 | |
| 3,507,000 | |
| 4,045,000 | |
| 5,028,000 | |
| 3,795,000 | |
| 5,683,000 | |
| 3,068,000 | |
| 3,930,000 | |
| 2,543,000 | |
| 1,662,000 | |
| 1,662,000 | |
| 1,134,000 | |
| 1,170,000 | |
| 2,152,000 | |
| 2,618,000 | |
| 3,599,000 | |
| 3,926,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 38,000 | |
| 0 | |
| 0 | |
| 0 | |
| 40,000 | |
| 0 | |
| 0 | |
| 0 | |
| 37,000 | |
| 0 | |
| 0 | |
| 0 | |
| 107,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 1,190,692 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |